TT-173

· Thrombotargets Europe S.L

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for TT-173, covering 2013-09-16 to 2018-02-22. Get the full timeline:

Most recent: Clinical Trial Update: Determine the Efficacy of TT-173. Reducing the the Total Blood Loss Associated With Total Knee Arthroplasty (HESTAT) [Phase 2, Phase 3]

See pricing